Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Active not recruiting 4 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Unknown Primary 1

Interventions

Cisplatin 349 Oxaliplatin 258 Capecitabine 257 Radiotherapy 238 Docetaxel 221 Gemcitabine 220 Carboplatin 220 Cyclophosphamide 215 Drug Therapy 214 apatinib 199 Paclitaxel 198 Bevacizumab 192 camrelizumab 188 Fluorouracil 186 sintilimab 131 Irinotecan 124 Blood Specimen Collection 123 Dexamethasone 122 Etoposide 118 Surgical Procedures, Operative 114 Radiosurgery 114 toripalimab 113 pembrolizumab 108 Pemetrexed 108 anlotinib 105 S 1 (combination) 104 Leucovorin 99 Surveys and Questionnaires 97 tislelizumab 95 Doxorubicin 95

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × FAPI-46 × Clear all

NCT05263700 2023-03-31

FAPI-CUP

Peter MacCallum Cancer Centre, Australia

Phase NA Unknown

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡